Spero Therapeutics Overview

  • www.sperotherapeutics.com
  • Cambridge, MA
  • 51 to 200 Employees
  • 2013
  • Company - Public (SPRO)
  • Biotech & Pharmaceuticals
  • $5 to $10 million (USD)

Spero Therapeutics is a global, multi-asset, clinical-stage biopharmaceutical company headquartered in Cambridge, Massachusetts.
Mission: Our mission is to become a leader in the field of Gram-negative antibiotics and we aim to achieve this objective by advancing multiple, differentiated products towards commercialization in key territories.

Glassdoor Awards

Top CEOs: 2021(#15)

Company Updates

October 13, 2021
KEY NOT FOUND: company-updates.categories.culture
Spero Therapeutics is excited to announce that we are winners of a 2021 CandE Award! Spero ranked #22 out of #132 companies that participated in North America. The CandE Award is a prestigious award in the Talent Acquisition and HR space that recognizes companies who have been identified as providing exceptional candidate care by the candidates who go through their interview process, over 80% of whom were not hired. The award is presented by the Talent Board; a non-profit organization focused on the elevation and promotion of a quality candidate experience. Winners were identified through a comprehensive data analysis based on their job candidates’ satisfaction survey scores. To qualify, each company committed to a statistically significant candidate response rate, where the proportion of respondents who were not hired met or exceeded a set standard.
Shared image - Talent Board Announces Winners of 2021 Global Candidate Experience Awards - Talent Board
Talent Board Announces Winners of 2021 Global Candidate Experience Awards - Talent Board
www.thetalentboard.org
October 13, 2021
KEY NOT FOUND: company-updates.categories.company-news
Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing, and commercializing treatments in high unmet need areas involving multi-drug resistant bacterial infections and rare diseases, today announced that it has entered into a revenue interest financing agreement with HealthCare Royalty Partners® for up to $125 million. Spero intends to use the proceeds from the agreement and existing cash on hand to prepare for the anticipated launch of tebipenem HBr, as well as to support the continued clinical development of SPR720 and SPR206.
Shared image - https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-enters-non-dilutive-revenue-interest
https://investors.sperotherapeutics.com/news-releases/news-release-details/spero-therapeutics-enters-non-dilutive-revenue-interest
investors.sperotherapeutics.com

Spero Therapeutics Reviews

5.0
100%
Recommend to a Friend
100%
Approve of CEO
Ankit Mahadevia, MD
Ankit Mahadevia, MD
42 Ratings
Top CEOs at SMBs 2021
5.0
Current Employee, less than 1 year

"Breath of Fresh Air"

Oct 15, 2021 - Director of National Accounts
Recommends
Positive Outlook
Approves of CEO

Pros

They emphasize culture and execute well on every core value.

Cons

Still working out some of the start up kinks - but doing it well.

Advice to Management

If you can keep the culture as the company grows, you deserve all the accolades
See All 47 Reviews

Diversity & Inclusion at Spero Therapeutics

4.7
(31 Reviews)

Diversity & Inclusion FAQs

All answers shown come directly from Spero Therapeutics Reviews and are not edited or altered.

How is diversity at Spero Therapeutics?

...The company cares about culture, diversity, and work...Read More

Read 2 more responses

Spero Therapeutics Interviews

Experience
Positive67%
Negative11%
Neutral22%
Getting an Interview
Applied online57%
Employee Referral43%
Difficulty
3.0
Average
HardAverageEasy

  1. Executive Assistant Interview

    Anonymous Employee in New York, NY
    No Offer
    Neutral Experience
    Average Interview

    Interview

    I had thought things were going well, and enjoyed meeting people at the company before suddenly being ghosted. It was very strange since I had been told not long before that I would be moving to the next stage of the process, and then all communication ceased and my calls and emails were not returned. I understand if the position has been filled, but ghosting candidates is not the right way to go about it.
    Interview

    General experience and personality questions.

    Answer Question

See All 9 interviews

Spero Therapeutics Awards & Accolades

  • Boston Business Journal Best Places to WorkThe Boston Business Journal2021
  • Boston Business Journal Best Places to WorkThe Boston Business Journal2020
  • Boston Business Journal Best Places to WorkThe Boston Business Journal2017

Popular Careers with Spero Therapeutics Job Seekers

JobsSalariesInterviews

Spero Therapeutics FAQ

(20 Questions)

All answers shown come directly from Spero Therapeutics Reviews and are not edited or altered.

See questions about:

What are perks and other benefits like at Spero Therapeutics?

...Great vision, company values and excellent benefits...

February 18, 2021

Read more

Work at Spero Therapeutics? Share Your Experiences

Spero Therapeutics logo
or